TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
11/13/24 20:30 | 11/11/24 | TWST | Twist Bioscience Corp | DE | Health | BioPrd | Biological Products, (No Diag | Chess Robert | CA | D | M.d | 32 | 8.82 | 0 | 4 | 6 | 64 | D | |||||||||||||||
11/13/24 20:30 | 11/11/24 | TWST | Twist Bioscience Corp | DE | Health | BioPrd | Biological Products, (No Diag | Chess Robert | CA | D | S.d | -170 | 47.26 | 0 | -4 | -5 | 64 | D | |||||||||||||||
6/14/24 18:02 | 6/14/24 | NKTR | Nektar Therapeutics | DE | Health | Drug | Pharmaceutical Preparations | Chess Robert | CA | D | S | -23 | 1.20 | 0 | -20 | -7 | 262 | D | |||||||||||||||
2/9/24 16:10 | 2/8/24 | TWST | Twist Bioscience Corp | DE | Health | BioPrd | Biological Products, (No Diag | Chess Robert | CA | D | S | -144 | 34.98 | 0 | -4 | -6 | 64 | D | |||||||||||||||
9/20/23 20:08 | 9/22/22 | NKTR | Nektar Therapeutics | DE | Health | Drug | Pharmaceutical Preparations | Chess Robert | CA | D | S.d | -7 | 0.6700 | 0 | -10 | -4 | 281 | D | |||||||||||||||
9/26/22 19:23 | 9/22/22 | NKTR | Nektar Therapeutics | DE | Health | Drug | Pharmaceutical Preparations | Chess Robert | CA | D | S | -16 | 3.19 | 0 | -5 | -2 | 291 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |